Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,127.7
5.2 (0.17%)

 

  • STI Straits Times Index
    3,127.7
    5.2 (0.17%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,602.5
    7.9 (0.49%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,048.7
    -221.3 (-0.84%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,883.4
    3.1 (0.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    20,628.0
    9.4 (0.05%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,239.2
    -13.7 (-0.22%)
    Index delayed 10 minutes
  • KOR KOSPI
    1,951.0
    -13.6 (-0.69%)
    Index delayed 20 minutes
  • XAO XAO
    6,593.0
    20.4 (0.31%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 792.8M
  • Value: 897.2M
  • Rise: 154
  • Fall: 151
  • Unch: 530

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
LionGold0.001-
ThaiBev0.930+0.005
YZJ Shipbldg SGD0.930-0.035
SingTel3.240+0.050
Rex Intl0.076-0.001
MMP Resources^0.003-0.001
Kep Infra Tr0.515+0.005
Koh Eco0.052+0.001
RHT HealthTrust0.019+0.001
Frasers L&I Tr1.190-0.030

World Indices

World Indices
Name Last Change
Nasdaq 8,020.2 +71.7
HSI 26,048.7 -221.3
HSCEI 10,122.9 -54.4
Jakarta 6,239.2 -13.7
Nikkei 225 20,628.0 +9.4
SSE Comp 2,883.4 +3.1
Shanghai A 3,020.7 +3.3
Shanghai B 264.3 -0.5
PSE Comp 0.0
KOSPI 1,951.0 -13.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AMARIN CORP ADR EACH REP 1 ORD GBP0.50 AMARIN CORPORATION PLC SPONSORED ADR
Updated on 21 Aug 2019 (End of trading day)
Last (USD): 16.050 Change: +0.620 High: 16.225 Remarks: -
Change (%): +4.02 Low: 15.500
Open 15.500 Yesterday's Close 15.430000000000001
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 8,319,672 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.32940 Trailing EPS (USD) e -0.23916 NAV (USD) b 0.3605
PE a - Trailing PE f - Price / NAV b 44.5215
Dividend (USD) d - Cash In Hand (USD) g 0.6327 Issued & Paid-up Shares c 352,909,000
Dividend Yield (%) d - Price / Cash In Hand g 25.367 Treasury Shares h 3,841,615
Beta - 75 Daysi -0.250 R-Squared - 75 Days(%)i 0.47 Market Cap (M) 5,664.189
Beta - 500 Daysi -0.128 R-Squared - 500 Days (%)i - Enterprise Value (M) 5,539.537
Piotroski F Score 4 Exchange Code AMRN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 183.06 Free Float (%) 99.6
Sector & Industry Health Technology - Pharmaceuticals: Other
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 23 Jul 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Aug 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AMARIN CORP ADR EACH REP 1 ORD GBP0.50 NASDAQ 5,664.189 - - 44.5215 -
Industry Pharmaceuticals: Other NASDAQ 1,113.245 - 295.091 4.9500 -
Local Peer SAGE THERAPEUTICS INC NASDAQ 8,669.607 - - 7.2074 -
Local Peer ICON NASDAQ 8,413.070 26.074 23.844 5.6240 -
Local Peer JAZZ PHARMACEUTICALS PLC NASDAQ 7,578.721 16.951 11.555 2.5403 -
Local Peer ARGENX SE SPON ADR EACH REP 1 ORD SHS NASDAQ 5,226.134 - - 6.8969 -
Local Peer HORIZON THERAPEUTICS PLC NASDAQ 5,214.951 - 68.976 3.4289 -
Local Peer GW PHARMACEUTICALS ADS EA REPR 12 ORD GBP0.00 NASDAQ 4,695.676 - - 6.4422 -
Local Peer CRONOS GROUP INC NASDAQ 4,033.824 - 8.143 4.3043 -
Local Peer UNITED THERAPEUTICS CORP NASDAQ 3,629.903 6.161 - 1.4188 -
Local Peer MEDICINES CO NASDAQ 2,721.705 - - 71.3840 -
Local Peer MYOKARDIA INC NASDAQ 2,570.156 - - 4.3996 -
Local Peer PORTOLA PHARMACEUTICALS INC NASDAQ 2,206.775 - - 3,705.1282 -
Local Peer INTERCEPT PHARMACEUTICALS INC NASDAQ 2,205.672 - - 12.5893 -
Other Local Peers ZOGENIX INC (NASDAQ), PACIRA BIOSCIENCES INC (NASDAQ), CORCEPT THERAPEUTICS INC (NASDAQ), SUPERNUS PHARMACEUTICALS INC (NASDAQ), MADRIGAL PHARMACEUTICALS INC (NASDAQ), IRONWOOD PHARMACEUTICALS INC (NASDAQ), THERAVANCE BIOPHARMA INC (NASDAQ), INNOVIVA INC (NASDAQ), ARQULE INC (NASDAQ), AMPHASTAR PHARMACEUTICALS INC (NASDAQ), AERIE PHARMACEUTICALS INC (NASDAQ), EAGLE PHARMACEUTICALS INC (NASDAQ), AXSOME THERAPEUTICS INC (NASDAQ), ANI PHARMACEUTICALS INC (NASDAQ), ORGANIGRAM HOLDINGS INC (NASDAQ), ANIKA THERAPEUTICS INC (NASDAQ), ENDO INTERNATIONAL PLC (NASDAQ), CATALYST PHARMACEUTICALS INC (NASDAQ), INTERSECT ENT INC (NASDAQ), REVANCE THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), COLLEGIUM PHARMACEUTICAL INC (NASDAQ), BIODELIVERY SCIENCES INTERNATIONAL (NASDAQ), ALBIREO PHARMA INC (NASDAQ), ASSEMBLY BIOSCIENCES INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), ZYNERBA PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), ACELRX PHARMACEUTICALS INC (NASDAQ), FOAMIX PHARMACEUTICALS LTD (NASDAQ), ADAMAS PHARMACEUTICALS INC (NASDAQ), CERECOR INC (NASDAQ), ACASTI PHARMA INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), HARROW HEALTH INC (NASDAQ), GALMED PHARMACEUTICALS LTD (NASDAQ), MEI PHARMA INC (NASDAQ), OASMIA PHARMACEUTICAL AB ADR EACH REP 3 ORD SHS (NASDAQ), NEOS THERAPEUTICS INC (NASDAQ), CUMBERLAND PHARMACEUTICALS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), AGILE THERAPEUTICS (NASDAQ), SCYNEXIS INC (NASDAQ), LIPOCINE INC (NASDAQ), MARINUS PHARMACEUTICALS INC (NASDAQ), VERONA PHARMA SPON ADR EACH REP 8 ORD SHS (NASDAQ), ORAMED PHARMACEUTICALS INC (NASDAQ), PLX PHARMA INC (NASDAQ), VIVUS INC (NASDAQ), CTI BIOPHARMA CORP (NASDAQ), ACLARIS THERAPEUTICS INC (NASDAQ), MELINTA THERAPEUTICS INC (NASDAQ), BIOLINE RX LTD SPON ADS EACH REPR 15 ORD SHS (NASDAQ), KEMPHARM INC (NASDAQ), EVOKE PHARMA INC (NASDAQ), CASSAVA SCIENCES INC (NASDAQ), TETRAPHASE PHARMACEUTICALS INC (NASDAQ), INTEC PHARMA LTD (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), REGULUS THERAPEUTICS INC (NASDAQ), SONOMA PHARMACEUTICALS INC (NASDAQ), RITTER PHARMACEUTICALS INC (NASDAQ), HEPION PHARMACEUTICALS INC (NASDAQ), MY SIZE INC (NASDAQ), TONIX PHARMACEUTICALS HLDG CORP (NASDAQ), EYEGATE PHARMACEUTICALS INC (NASDAQ)
Global Peer CATALENT INC NYSE 8,116.325 97.086 54.472 5.0079 -
Global Peer FOSUN PHARMA HKEx 57,921.563 18.059 18.157 1.7265 1.593
Global Peer BAUSCH HEALTH COMPANIES INC NYSE 7,890.803 - - 2.2588 -
Global Peer PERRIGO COMPANY PLC NYSE 6,519.756 49.769 75.112 1.1386 1.584
Global Peer AURORA CANNABIS INC NYSE 5,953.646 105.131 - - -
Global Peer Kalbe Farma Tbk. IDX 76,172,037.500 31.000 30.476 5.1942 1.600
Global Peer SH PHARMA HKEx 42,119.818 9.163 9.007 0.8991 3.150
Global Peer LUYE PHARMA HKEx 21,702.001 14.058 14.058 2.4372 1.713
Global Peer SSY GROUP HKEx 20,692.085 22.694 22.694 4.8819 1.311
Global Peer LIVZON PHARMA HKEx 19,489.788 15.205 14.237 1.6267 5.037
Other Global Peers HEC PHARM (HKEx), SIHUAN PHARM (HKEx), PRESTIGE CONSUMER HEALTHCARE INC (NYSE), APHRIA INC (NYSE), TONG REN TANG (HKEx), Kimia Farma (Persero) Tbk. (IDX), C ANIMAL HEALTH (HKEx), HEXO CORP (NYSE), CLINUVEL PHARMACEUTICALS LTD (ASX), MEGA (SET), BLACKMORES LTD (ASX), FUDANZHANGJIANG (HKEx), Tianjin ZX USD (SGX), Tempo Scan Pacific Tbk. (IDX), CONSUN PHARMA (HKEx), HUA HAN HEALTH (HKEx), Indofarma (Persero) Tbk. (IDX), OPTHEA LIMITED (ASX), MALLINCKRODT PLC (NYSE), SHANDONG XINHUA (HKEx), CANNTRUST HOLDINGS INC (NYSE), ELIXINOL GLOBAL LTD (ASX), GOLDEN THROAT (HKEx), OCI INTL (HKEx), DOD (SET), BOTANIX PHARMACEUTICALS LTD (ASX), ALTHEA GROUP HOLDINGS LTD (ASX), IX Biopharma (SGX), YSPSAH (Bursa), LONGRUN TEA (HKEx), JILIN CHANGLONG (HKEx), INVION LTD (ASX), TIANDA PHARMA (HKEx), PHARMAXIS (ASX), EAGLE HEALTH HOLDINGS LTD (ASX), LANSEN PHARMA (HKEx), MGC PHARMACEUTICALS LTD (ASX), THC GLOBAL GROUP LTD (ASX), SANAI HEALTH GP (HKEx), AMPIO PHARMACEUTICALS INC (NYSE American), VITA LIFE SCIENCES LIMITED (ASX), IDT AUSTRALIA LIMITED (ASX), ACRUX (ASX), COGSTATE (ASX), PHARMAUST LIMITED (ASX), ANTISENSE THERAPEUTICS (ASX), C HEALTH GP (HKEx), BAYTACARE PHARM (HKEx), CANNPAL ANIMAL THERAPEUTICS LTD (ASX), Pyridam Farma Tbk (IDX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.610
+11.15 %
10 Days --1.760
-9.88 %
20 Days --2.440
-13.20 %
Medium Term Return 3 Months --1.230
-7.12 %
6 Months --1.380
-7.92 %
1 Year -+13.300
+483.64 %
Long Term Return 2 Years -+12.900
+409.52 %
3 Years -+12.980
+422.80 %
5 Years -+14.130
+735.94 %
Annualised Return Annualised --
+52.91 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2.650 - 23.910 Change From 1 Year Low +13.400 % Change From 1 Year Low (%) +505.64
Change From 1 Year High -7.860 % Change From 1 Year High (%) -32.87
2 Years Range 2.350 - 23.910 Change From 2 Years Low +13.700 % Change From 2 Years Low (%) +582.98
Change From 2 Years High -7.860 % Change From 2 Years High (%) -32.87
5 Years Range 0.780 - 23.910 Change From 5 Years Low +15.270 % Change From 5 Years Low (%) +1957.69
Change From 5 Years High -7.860 % Change From 5 Years High (%) -32.87
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Historical Price Data

Date Open High Low Close Volume VWAP
21 Aug 2019 15.500 16.225 15.500 16.050 8,319,672 -
20 Aug 2019 15.610 15.730 15.060 15.430 5,449,110 -
19 Aug 2019 15.420 15.835 15.200 15.660 8,241,135 -
16 Aug 2019 14.630 15.190 14.510 15.150 7,219,547 -
15 Aug 2019 14.940 15.140 14.185 14.440 7,888,956 -
14 Aug 2019 14.260 14.970 14.220 14.820 9,719,333 -
13 Aug 2019 13.840 14.413 13.800 14.290 8,115,116 -
12 Aug 2019 14.780 14.880 13.760 13.890 15,439,170 -
09 Aug 2019 14.640 15.430 14.500 14.770 28,421,720 -
08 Aug 2019 17.010 17.887 16.950 17.810 11,314,030 -
07 Aug 2019 16.800 17.000 16.520 16.860 4,867,793 -
06 Aug 2019 17.070 17.230 16.720 17.060 5,483,860 -
05 Aug 2019 17.000 17.000 16.370 16.800 9,471,082 -
02 Aug 2019 17.980 17.980 17.070 17.250 8,672,178 -
01 Aug 2019 18.590 18.600 17.760 17.800 9,245,087 -
31 Jul 2019 19.040 20.510 17.250 18.590 12,251,920 -
30 Jul 2019 18.200 18.520 17.950 18.440 6,123,471 -
29 Jul 2019 18.400 18.460 18.010 18.140 5,563,057 -
26 Jul 2019 18.600 18.790 18.135 18.320 5,956,876 -
25 Jul 2019 18.530 18.770 18.300 18.490 6,834,430 -
24 Jul 2019 18.480 18.660 18.085 18.570 8,854,942 -
23 Jul 2019 18.160 18.220 17.600 18.010 10,078,000 -
Summary
Current 2 Weeks
(08 Aug 2019 to 21 Aug 2019)
17.010 17.887 13.760 16.050 110,127,789 -
Previous 2 Weeks
(25 Jul 2019 to 07 Aug 2019)
18.530 18.770 13.760 16.860 74,469,754 -
4 Weeks from
(26 Jun 2019 to 24 Jul 2019)
18.430 18.450 13.760 18.570 255,874,931 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.